It has been agreed upon for several weeks and was already confirmed at the meeting of the Administrative Committee of the Unified Patent Court (UPC)
Continue reading
What is the UPCLA network? The UPCLA network, created in 2014, is a non-exclusive network of European law...
Continue reading
The so-called grace period for use in the EU Trademark Regulation is intended to give applicants the opportunity to protect their trademark and thus an important marketing too...
Continue reading
All articles
We are happy to report that the oppositions filed by our client betapharm and eight other generics manufacturers against Novartis patent EP 3 351 246 were successful; the Board of Appeal of the European Patent Office revoked the Novartis patent for lack of inventive step (fi...
Continue reading
We are happy to report that the oppositions filed by our client betapharm and eight other generics manufacturers against Novartis patent EP 3 351 246 were successful; the Board of Appeal of the European Patent Office revoked the Novartis patent for lack of inventive step (fi...
Continue reading
At the end of June, the Federal Patent Court declared a Novartis patent (EP 3 143 990 B1) null and void in its entirety for lack of inventive step (file no. : 3 Ni 13/22). Novartis ma...
Continue reading
Maiwald in the press
We would like to congratulate Dr Matthias Hoffmann and
Continue reading
Maiwald, one of Germany's leading IP law firms, has appointed Martina Boidol...
Continue reading
We are very happy to congratulate Dr Quirin Spiller and
Continue reading
Staff News
The creation of the unitary patent and the Unified Patent Court (“UPC”) heralds the beginning of a new era in patent law in Europe. The Agreement on a Unified Patent Court...
Continue reading
In a recent article published by Managing IP, Dr M...
Continue reading
On April 27, 2023, the European Commission presented four proposals for Regulations on supplementary protection certificates as part of the Intellectual Property Action Plan. ...
Continue reading
All publications
This year, FOCUS presented Germany's top commercial law firms for the eleventh time in a row. We are delighted that we were able to convince and belong to the top commerci...
Continue reading
We are very delighted to be once again recognized by Managing IP (MIP) as "Top Tier Firm" in the IP STARS Ranking 2023. By being awarded in the categories "Patent Prosecution ...
Continue reading
All awards
Wed.
20
BioTechX Europe is Europe’s largest congress covering diagnostics, precision medicine and digital transformation in pharmaceutical development and healthcare. In 2023 the 3-day event will return to Basel, the pharma hub of Europe, this time with 2500 leaders in the field, 450 speakers and 100 start-ups all under one ro...
Continue reading
Thu.
7
We are pleased to be a Gold Sponsor of the Life Sciences Strategy Summit in IP & Exclusivity. Dr Eva Ehlich and Dr Annelie Wünsche will be speaking at a roundtable on "Freedom to Operate - Analysi...
Continue reading
All events